AB, H., R, E. A., N, T., A, T., C, T., M, J., . . . SS, A. (2025). Insight into Predictors of Cytoreduction Score Following Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy for Gastric Peritoneal Carcinomatosis Improves Patient Selection and Prognostic Outcomes. Annals of surgical oncology, 32(1), 199. https://doi.org/10.1245/s10434-024-16328-z
Chicago Style (17th ed.) CitationAB, Hamed, et al. "Insight into Predictors of Cytoreduction Score Following Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy for Gastric Peritoneal Carcinomatosis Improves Patient Selection and Prognostic Outcomes." Annals of Surgical Oncology 32, no. 1 (2025): 199. https://doi.org/10.1245/s10434-024-16328-z.
MLA (9th ed.) CitationAB, Hamed, et al. "Insight into Predictors of Cytoreduction Score Following Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy for Gastric Peritoneal Carcinomatosis Improves Patient Selection and Prognostic Outcomes." Annals of Surgical Oncology, vol. 32, no. 1, 2025, p. 199, https://doi.org/10.1245/s10434-024-16328-z.
